Andrew Abbott is an economist with broad experience providing financial, economic, and econometric analysis in connection with high-stakes litigation in the areas of antitrust and consumer fraud. Mr. Abbott has extensive experience advising clients in all aspects of litigation consulting including market research, big data and document analytics, the development of econometric and statistical models used to measure antitrust impact and damages, and the preparation of expert testimony. Mr. Abbott is well-adept at developing and implementing comprehensive analyses to address multifaceted issues related to allegations of horizontal price-fixing, monopolization, supply restrictions, market allocation, and bid rigging. His work focuses primarily on healthcare and agricultural markets.
Mr. Abbott specializes in analyzing complex pharmaceutical and healthcare markets at the direct and indirect purchaser levels. He is well versed in the pharmaceutical distribution system and the inherent complexities of analyzing injury and damages incurred by payors resulting from anticompetitive hospital mergers, as well as unlawful pay-for-delay and product hopping schemes. Mr. Abbott has developed sophisticated methodologies to analyze antitrust injury, unjust enrichment, and class-wide damages that account for the unique characteristics of the healthcare market including:
- Formulary Placement
- Benefit Design
- Medicare Part-D
- Rebates and Price Adjustments
Do you need industry experts for your next case?